224 related articles for article (PubMed ID: 30012153)
1. Myricetin antagonizes semen-derived enhancer of viral infection (SEVI) formation and influences its infection-enhancing activity.
Ren R; Yin S; Lai B; Ma L; Wen J; Zhang X; Lai F; Liu S; Li L
Retrovirology; 2018 Jul; 15(1):49. PubMed ID: 30012153
[TBL] [Abstract][Full Text] [Related]
2. Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection).
Roan NR; Sowinski S; Münch J; Kirchhoff F; Greene WC
J Biol Chem; 2010 Jan; 285(3):1861-9. PubMed ID: 19897482
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infection.
Olsen JS; Brown C; Capule CC; Rubinshtein M; Doran TM; Srivastava RK; Feng C; Nilsson BL; Yang J; Dewhurst S
J Biol Chem; 2010 Nov; 285(46):35488-96. PubMed ID: 20833717
[TBL] [Abstract][Full Text] [Related]
4. ADS-J1 inhibits semen-derived amyloid fibril formation and blocks fibril-mediated enhancement of HIV-1 infection.
Xun T; Li W; Chen J; Yu F; Xu W; Wang Q; Yu R; Li X; Zhou X; Lu L; Jiang S; Li L; Tan S; Liu S
Antimicrob Agents Chemother; 2015 Sep; 59(9):5123-34. PubMed ID: 26055369
[TBL] [Abstract][Full Text] [Related]
5. The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection.
Roan NR; Münch J; Arhel N; Mothes W; Neidleman J; Kobayashi A; Smith-McCune K; Kirchhoff F; Greene WC
J Virol; 2009 Jan; 83(1):73-80. PubMed ID: 18945786
[TBL] [Abstract][Full Text] [Related]
6. The anti-parasitic drug suramin potently inhibits formation of seminal amyloid fibrils and their interaction with HIV-1.
Tan S; Li JQ; Cheng H; Li Z; Lan Y; Zhang TT; Yang ZC; Li W; Qi T; Qiu YR; Chen Z; Li L; Liu SW
J Biol Chem; 2019 Sep; 294(37):13740-13754. PubMed ID: 31346035
[TBL] [Abstract][Full Text] [Related]
7. Polyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infection.
Tan S; Lu L; Li L; Liu J; Oksov Y; Lu H; Jiang S; Liu S
PLoS One; 2013; 8(3):e59777. PubMed ID: 23544097
[TBL] [Abstract][Full Text] [Related]
8. Natural Seminal Amyloids as Targets for Development of Synthetic Inhibitors of HIV Transmission.
Sheik DA; Dewhurst S; Yang J
Acc Chem Res; 2017 Sep; 50(9):2159-2166. PubMed ID: 28809479
[TBL] [Abstract][Full Text] [Related]
9. SEVI, the semen enhancer of HIV infection along with fragments from its central region, form amyloid fibrils that are toxic to neuronal cells.
Elias AK; Scanlon D; Musgrave IF; Carver JA
Biochim Biophys Acta; 2014 Sep; 1844(9):1591-8. PubMed ID: 24948476
[TBL] [Abstract][Full Text] [Related]
10. Tolcapone Potently Inhibits Seminal Amyloid Fibrils Formation and Blocks Entry of Ebola Pseudoviruses.
Qiu M; Li Z; Chen Y; Guo J; Xu W; Qi T; Qiu Y; Pang J; Li L; Liu S; Tan S
Front Microbiol; 2020; 11():504. PubMed ID: 32425892
[TBL] [Abstract][Full Text] [Related]
11. Repurposing Hsp104 to Antagonize Seminal Amyloid and Counter HIV Infection.
Castellano LM; Bart SM; Holmes VM; Weissman D; Shorter J
Chem Biol; 2015 Aug; 22(8):1074-86. PubMed ID: 26256479
[TBL] [Abstract][Full Text] [Related]
12. Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection.
Roan NR; Müller JA; Liu H; Chu S; Arnold F; Stürzel CM; Walther P; Dong M; Witkowska HE; Kirchhoff F; Münch J; Greene WC
Cell Host Microbe; 2011 Dec; 10(6):541-50. PubMed ID: 22177559
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the Influence of Semen-Derived Enhancer of Virus Infection on the Interaction of HIV-1 with Female Reproductive Tract Tissues.
Allen SA; Carias AM; Anderson MR; Okocha EA; Benning L; McRaven MD; Kelley ZL; Lurain J; Veazey RS; Hope TJ
J Virol; 2015 May; 89(10):5569-80. PubMed ID: 25740984
[TBL] [Abstract][Full Text] [Related]
14. Seminal plasma accelerates semen-derived enhancer of viral infection (SEVI) fibril formation by the prostatic acid phosphatase (PAP248-286) peptide.
Olsen JS; DiMaio JT; Doran TM; Brown C; Nilsson BL; Dewhurst S
J Biol Chem; 2012 Apr; 287(15):11842-9. PubMed ID: 22354963
[TBL] [Abstract][Full Text] [Related]
15. ADS-J1 disaggregates semen-derived amyloid fibrils.
Li J; Yang Z; Liu H; Qiu M; Zhang T; Li W; Li Z; Qi T; Qiu Y; Li L; Zhou X; Liu S; Tan S
Biochem J; 2019 Mar; 476(6):1021-1035. PubMed ID: 30877194
[TBL] [Abstract][Full Text] [Related]
16. [PSB0739 inhibits formation of semen-derived amyloid fibril].
Lan Y; Yang Z; Liu H; Cheng H; Liu S; Tan S
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1338-1343. PubMed ID: 30514682
[TBL] [Abstract][Full Text] [Related]
17. A molecular tweezer antagonizes seminal amyloids and HIV infection.
Lump E; Castellano LM; Meier C; Seeliger J; Erwin N; Sperlich B; Stürzel CM; Usmani S; Hammond RM; von Einem J; Gerold G; Kreppel F; Bravo-Rodriguez K; Pietschmann T; Holmes VM; Palesch D; Zirafi O; Weissman D; Sowislok A; Wettig B; Heid C; Kirchhoff F; Weil T; Klärner FG; Schrader T; Bitan G; Sanchez-Garcia E; Winter R; Shorter J; Münch J
Elife; 2015 Aug; 4():. PubMed ID: 26284498
[TBL] [Abstract][Full Text] [Related]
18. Oligovalent amyloid-binding agents reduce SEVI-mediated enhancement of HIV-1 infection.
Capule CC; Brown C; Olsen JS; Dewhurst S; Yang J
J Am Chem Soc; 2012 Jan; 134(2):905-8. PubMed ID: 22239120
[TBL] [Abstract][Full Text] [Related]
19. [ADS-J1 antagonizes semen-derived enhancer of virus infection-mediated enhancement of transmitted founder HIV-1 and its matched chronic control strain infection].
Liu HM; Ma NN; Luo C; Yuan SY; Liu FL; Yao XG; Zhou CQ; Zou M
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Feb; 38(2):211-216. PubMed ID: 29502062
[TBL] [Abstract][Full Text] [Related]
20. Semen-derived amyloidogenic peptides-Key players of HIV infection.
Lee YH; Ramamoorthy A
Protein Sci; 2018 Jul; 27(7):1151-1165. PubMed ID: 29493036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
